PE / VC
1998
$20 000 M
Boston, Massachusetts, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Based in Boston and New York, Charlesbank Capital Partners is a middle-market private investment firm with approximately $20 billion in AUM as of 12/31/2024. Charlesbank focuses on management-led buyouts and growth capital financings, as well as opportunistic credit and technology investments. The firm seeks to build companies with sustainable competitive advantage and excellent prospects for growth.
----
Charlesbank’s principals have a long history of working together, a deep specialization in the middle market and a record of solid returns over multiple business cycles. We bring a flexible approach to the structure of each portfolio company investment and are comfortable working in scenarios that are complex or difficult to underwrite.
For more information please visit: www.charlesbank.com.
Disclaimer: The information on this page is for informational purposes only. Nothing on or within this page constitutes a solicitation, offer, recommendation or representation of suitability or endorsement of any security or investment or any product of Charlesbank or Charlesbank-managed funds. Charlesbank is not responsible for any content posted by third parties to this page.
Industry
Region of investment
Charlesbank Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Charlesbank Equity Fund VIII, LP
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Industrial
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$1800 M
|
July 2014
|
|
Charlesbank Equity Fund IX
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Industrial
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$2800 M
|
October 2017
|
|
Charlesbank Equity Fund X, LP
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Industrial
|
Series B
Late Stage (Series C+)
|
North America
Europe
|
$5-10 m
|
$3800 M
|
February 2021
|